CDSCO plans to approve Covid-19 vaccines showing 50 percent efficacy in clinical trial Farhat Nasim22 Sept 2020 6:51 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has recently issued draft guidelines that plan to approve COVID-19 vaccines that...
Union Minister Gowda lauds contribution of Indian pharma industry amid COVID-19 crisis Ruchika Sharma20 Sept 2020 11:30 AM ISTUnion Minister also stressed that the Indian pharma and medical devices industry was able to rise to the occasion.
COVID Vaccine Sputnik V: Significant movement on Russian request for phase-3 trial in India Farhat Nasim11 Sept 2020 9:00 AM IST“We are paving was for such a phase-3 trial or bridging studies, as per requirements of the regulatory system, to be facilitated by the government of...
Suspension of Covishield trials in UK spells havoc for Astrazeneca and Serum Institute of India Ruchika Sharma10 Sept 2020 1:58 PM ISTNew Delhi: Owing to a suspected severe adverse reaction on a participant after being administered a booster dose of Covishield, the Drugs Controller...
Bharat Biotech Covid-19 vaccine phase-2 trial to begin in PGI Rohtak Medical Dialogues Bureau10 Sept 2020 10:15 AM IST"In India, Bharat Biotech's vaccine candidate based on inactivated virus procured by ICMR is in the Phase II trial along with Zydus Cadila's candidate...
Russian COVID vaccine Sputnik V induces antibody response in small human trials Medical Dialogues Bureau5 Sept 2020 11:36 AM ISTThese vaccines aim to stimulate both arms of the immune system -- antibody and T cell responses -- so they attack the virus when it is circulating in...
Bharat Biotech, Zydus Cadila COVID-19 vaccine in phase 2 trial, says VK Paul Medical Dialogues Bureau1 Sept 2020 10:15 AM ISTNew Delhi: Bharat Biotech's vaccine candidate based on inactivated virus procured by ICMR and Zydus Cadila's candidate based on viral DNA are two...
French drugmaker Sanofi more confident about its COVID vaccines: Report Farhat Nasim31 Aug 2020 9:45 AM IST“Our confidence has increased. We have work to do like everybody on manufacturing in large volumes. But we will have one, maybe two vaccines next...
Govt amends CSR norms to allow pharma firms to contribute to COVID-19 RnD; Details Farhat Nasim27 Aug 2020 5:43 PM ISTNew Delhi: Through a recent Gazette notification, the Government has amended the Companies Corporate Social Responsibility Policy (CSR) Rules, 2014 to...
Bharat Biotech gets CDSCO green flag to conduct Covaxin trial via Intradermal route Farhat Nasim24 Aug 2020 2:19 PM ISTNew Delhi: In a major advancement, Hyderabad-based drugmaker Bharat Biotech has secured permission from Central Drugs Standard Control Organisation...
COVID-19 Vaccine candidates progressing well, working to ramp up capacity with facilitations: Dr VK Paul Medical Dialogues Bureau20 Aug 2020 9:00 AM ISTNew Delhi - More than 3 crore tests conducted so far, while 8,99,864 tests, which is the highest number of tests in a single day, have been conducted...
Oxford-AstraZeneca Covid-19 vaccine gets ICMR nod to begin trials at KEM, Nair hospitals Farhat Nasim19 Aug 2020 4:10 PM ISTMumbai: The Oxford University-Astra Zeneca Covid-19 vaccine, Covishield will undergo Phase 2 and Phase 3 clinical trials by August-end at two...
